Last reviewed · How we verify
NCT05968807
iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients
NA trial testing iParent2Parent Program in Solid Organ Transplant in 55 participants. Currently enrolling.
26 June 2026
Quick facts
| Lead sponsor | The Hospital for Sick Children |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 55 |
| Start date | 1 August 2023 |
| Primary completion | 26 June 2026 |
| Estimated completion | 26 June 2026 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- iParent2Parent Program
Conditions studied
- Solid Organ Transplant — all drugs for Solid Organ Transplant →
Sponsor
The Hospital for Sick Children
Who can join
Adults 18 to 75, any sex, with Solid Organ Transplant. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The iParent2Parent (iP2P) program is a new, innovative virtual mentorship program that will connect parents one-to-one with other parents of pediatric solid organ transplant (SOT) recipients who are trained to offer vital peer support and mentorship. Parents of children who received a SOT at The Hospital for Sick Children will be invited to participate as mentors and mentees (randomized into the iP2P or control group). The iP2P program can decrease feelings of isolation, improve mental health and have a long-term positive impact on patient health. This research will increase our understanding of one-to-one peer support and leverage eHealth technologies to improve the access to and acceptability of parent peer support interventions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05968807
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of iParent2Parent Program
Trials testing the same drug.
- NCT05968833 — iParent2Parent Peer Support Program for Parents of Pediatric Kidney Transplant Recipients · NA · recruiting
- NCT04168034 — iParent2Parent Program for Parents of Children With Juvenile Idiopathic Arthritis · NA · completed
Other recruiting trials for Solid Organ Transplant
Currently open trials in the same condition.
- NCT04613206 — High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients · Phase 2 · active not recruiting
Other The Hospital for Sick Children trials
Trials by the same sponsor.
- NCT07454681 — MRI Assessment of Lung Airways in Cystic Fibrosis: Evaluate MRI's Ability to Detect Changes in Airway Structure . · not yet recruiting
- NCT07452575 — 3D Ultrasound in Hemophilic Ankles · NA · not yet recruiting
- NCT07508826 — AI-assisted Endotracheal Intubation · NA · not yet recruiting
- NCT07345819 — Dexamethasone vs. Placebo in Children and Youth Hospitalized for Orbital Cellulitis · NA · not yet recruiting
- NCT07497178 — MRgFUS for Childhood Epilepsy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05968807 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Hospital for Sick Children
- Last refreshed: 16 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05968807.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing